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Abstract : Two types of amniotic fluid embolism (AFE) have been described : cardiopulmonary collapse type and 
disseminated intravascular coagulation (DIC) type, with the latter proposed as uterine type. This report de-
scribes a healthy 28-year-old woman who developed AFE during a cesarean section. Because of a previous ce-
sarean section, the patient underwent an elective cesarean section, under combined spinal-epidural anesthesia, 
at 38 weeks of pregnancy. She began coughing 5 minutes after delivery of the fetus, subsequently becoming 
unconscious and developing glossoptosis and bradycardia. Her blood pressure decreased to 76/43 mmHg, and 
AFE was suspected. Her uterus was atonic, and she experienced persistent noncoagulant bleeding, with a final 
blood loss of 6300 ml. Considerable blood transfusion was required. The patient survived, and she and her baby 
were discharged without any sequelae on the eighth postoperative day. This patient met the Japanese criteria 
for clinical AFE, with an obstetrical DIC score of 21 meeting the criteria for obstetrical DIC. Early diagnosis and 
treatment likely resulted in patient survival. J. Med. Invest. 67 : 207-210, February, 2020
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INTRODUCTION
 
Amniotic fluid embolism (AFE) is a rare disease caused by 
the flow of amniotic fluid or fetal components into the maternal 
bloodstream. Two types of AFE have been described : car-
diopulmonary collapse type and disseminated intravascular 
coagulation (DIC) type, with the latter proposed as uterine type 
(1). Cardiopulmonary collapse type starts with pulmonary/respi-
ratory symptoms but uterine type starts with atonic bleeding/
DIC (2).
This report describes a patient with cardiopulmonary collapse 
type AFE and obstetrical DIC during an elective cesarean sec-
tion under combined spinal-epidural anesthesia. The patient 
developed dyspnea and hypotension 5 minutes after cesarean de-
livery, followed by DIC, suggesting AFE. Transesophageal echo-
cardiography (TEE) indicated collapse of the right heart, but not 
right ventricular failure. The patient was effectively treated for 
AFE, and she and her baby were able to leave the hospital safely. 
CASE REPORT
A 28-year-old woman underwent an elective cesarean section 
at 38 weeks of pregnancy because of a previous cesarean section. 
Her preoperative general condition was good. At 22 weeks of 
pregnancy, she had undergone fetal thoracoamniotic shunting 
under general anesthesia for fetal pleural fluid, but her subse-
quent course was good. Preoperative laboratory findings were as 
follows : hemoglobin concentration 10.5 g/dl, platelet count 34.3 
x 104/µL, prothrombin time-international normalized ratio (PT-
INR) 0.94, activated partial thromboplastin time (APTT) 25.3 
sec, and fibrinogen (FIB) concentration 672 mg/dl. Preoperative 
electrocardiogram and chest X-ray were normal. 
Surgery was performed under combined spinal-epidural an-
esthesia. Before anesthesia, her blood pressure (BP) was 114/67 
mmHg and her heart rate (HR) was 102 bpm. An epidural cath-
eter was placed on Th11/Th12, and 2.0 ml of 0.5% hypervaric 
bupivacaine 10 mg and 10 µg fentanyl were administered to the 
spinal subarachnoid space from L3/L4. Surgery was started 10 
minutes after anesthesia, and the fetus was delivered 10 min-
utes later. The patient began coughing 5 minutes after delivery 
of the fetus, subsequently becoming unconscious and developing 
glossoptosis. Her HR dropped to about 30 bpm for a few seconds, 
spontaneously recovering a few seconds later to 73 bpm, and her 
BP decreased to 76/43 mmHg, suggesting AFE. Although she 
returned to consciousness 5 minutes later, general anesthesia 
was induced. Sedation was started and her trachea was intubat-
ed. Eight minutes later, hemodynamics were assessed by TEE, 
which showed that her entire heart was hyperkinetic and that 
her right heart had collapsed. Approximately 30 minutes after 
delivery of the fetus, she had lost approximately 800 ml blood. 
Her BP decreased to 56/32 mmHg and her HR increased to 
125 bpm, making her Shock Index ≥ 2. Her uterus was atonic, 
and noncoagulant bleeding persisted. Blood transfusion and 
adrenaline treatment were started. After two bolus injections of 
0.1 mg adrenaline, she was started on continuous infusion of 0.1 
µg/kg/min adrenaline, along with 0.3 µg/kg/min noradrenaline. 
The Journal of Medical Investigation    Vol. 67  2020
　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　
Received for publication September 13, 2019 ; accepted October 31, 
2019.
Address correspondence and reprint requests to Yuki Ishikawa, M.D., 
Clinical Fellow, Department of Anesthesiology, Tokushima University 
Graduate School, 3-18-15 Kuramoto, Tokushima 770-8503, Japan and 
Fax : +81-886-33-7182.
207
208 Y. Ishikawa, et al.  Anesthetic Care of a Patient with AFE
When her fibrinogen concentration dropped to 106 mg/dl, she 
was administered a cryoprecipitate made of 12 units of fresh 
frozen plasma (FFP), along with platelet concentrate (PC). After 
attainment of a degree of surgical hemostasis and stabilization 
of vital signs, the operation was completed. Her uterus was 
saved, and she was transferred to the ICU without extubation 
and without treatment with catecholamines. Her final blood loss 
was 6300 ml. During the surgery, which lasted 5 hours and 55 
minutes, she was administered 18 units of red blood cells (RBC), 
18 units of FFP, 10 units of PC, and cryoprecipitate made from 
12 units of FFP. Intraoperative anesthetic course is shown in 
Figure 1.
Blood samples were obtained immediately after the sudden 
change in patient condition. Intraoperative serum laboratory 
findings were as follows : zinc coproporphyrin-1 (Zn-CP1) < 1.6 
pmol/mL (normal, < 1.6 pmol/mL), sialyl-Tn antigen (STN) 36 U/
mL (normal, < 45 U/mL), complement factor 3 (C3) 111.0 mg/dL 
(normal, 80–140 mg/dL), C4 11.0 mg/dL (normal, 11.0–34.0 mg/
dL), and C1 inhibitor activity < 25% (normal, > 42.0%) (Table1). 
Zn-CP1 and STN are markers indicating that amniotic fluid 
has flowed into maternal blood. C1 inhibitor activity and C3 
and C4 concentrations are often low in patients with AFE. In 
the present case, Zn-CP1 and STN concentrations were within 
normal ranges, with only C1 inhibitor activity being below the 
standard value.
Two hours after admission to the ICU, her vital signs became 
stable and the patient was extubated. She was conscious, with no 
neurological abnormalities. She was administered four units of 
FFP and 10 units of PC on the first postoperative day, with no 
further blood transfusions required. She and her baby showed 
good progress, and both were discharged on the eighth postop-
erative day.
DISCUSSION
AFE is a very rare disease, with an incidence of approximately 
1 in 40,000 deliveries, but has a high mortality rate, ranging 
from 20% to 60% (3). The cardiopulmonary collapse type of AFE 
is thought to be due to mechanical obstruction of the pulmonary 
artery by amniotic fluid, whereas the uterine type is thought to 
be due primarily to anaphylactoid reaction mechanisms (4, 5). 
The characteristics of this patient met the Japanese criteria 
for clinical AFE (Table 2) (6). Moreover, her obstetrical DIC 
score was 21 (Table 3), indicating that she met the criteria for 
Figure 1.　Intraoperative anesthetic course. FFP, fresh frozen plasma ; PC, platelet concentrate ; RBC, red blood cell. A : Fetal delivery, 
the Apgar score was 7 (one minute) and 10 (five minutes). B : Suddenly she began coughing, subsequently becoming unconscious. The heart 
rate dropped to about 30 bpm for a few seconds. C : She returned to consciousness, but general anesthesia was induced. D : Hemodynamics 
was assessed by transesophageal echocardiography. E : Hemoglobin concentration 4.9 g/dl, platelet count 17.4 x 104/µL, prothrombin time-
international normalized ratio (PT-INR) 2.22, activated partial thromboplastin time (APTT) 67.4 sec, fibrinogen (FIB) concentration 106 mg/dl, 
and antithrombin III activity 43.9%.
Table 1.　Auxiliary diagnostic markers of AFE in blood
Inspection items Results Normal values
Zn-CP1 < 1.6 pmol/ml < 1.6 pmol/ml
STN 36.0 U/ml < 45.0 U/ml
Complement C3 111.0 mg/dl 80-140 mg/dl
Complement C4 11.0 mg/dl 11.0-34.0 mg/dl
C1 inhibitor activity < 25.0 % > 42.0 %
AFE, amniotic fluid embolism ; STN, Sialyl-Tn ; Zn-CP1, Zinc-co-
proporphyrin-1.
Only C1 inhibitor activity was outside the normal value.
Table 2.　Japanese criteria of amniotic fluid embolism (AFE)
(1) If symptoms appeared during pregnancy or within12 h of delivery.
(2) If any intensive medical intervention was conducted to treat one or 
more of the following symptoms/diseases : 
  A) Cardiac arrest
  B) Severe bleeding of unknown origin within 2 h of delivery ( ≥ 1500 mL)
  C) Disseminated intravascular coagulation
  D) Respiratory failure
(3) If the findings or symptoms obtained cannot be explained by other dis-
eases.
A clinical diagnosis of AFE can be made if the pathological condition 
meets the above three criteria.
Because these diagnostic criteria serve the purpose of making a clinical 
diagnosis and being able to promptly provide treatment, the pathological 
conditions that meet them may include those other than AFE.
This case met (1), (2) C, (3) above.
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Table 3.　Obstetrical DIC score
1. Underlying diseases ; Only one of these items will be adopted as the score of underlying diseases. (Score)
a. Placental abruption
• Stiffening of the uterus, death of the fetus (5)
• Stiffening of the uterus, survival of the fetus (4)
• Confirmatory diagnosis of placental abruption by ultrasonic tomographic findings and CTG findings (4)
b. Amniotic fluid embolism
• Acute cor pulmonale (4)
• Artificial ventilation (3)
• Assisted respiration (2)
• Oxygen flux alone (1)
c. DIC-type postpartum hemorrhage
• In case the blood from the uterus has low coagulability (4)
• Hemorrhage of 2000 mL ≤ (within 24 h after the start of hemorrhage) (3)
• Hemorrhage of 1000 mL ≤ , but not exceeding 2000 mL (within 24 h after the start of hemorrhage) (1)
d. Eclampsia
• Eclamptic attack (4)
e. Severe infection
• Those with fever accompanied by shock, bacteremia, and endotoxemia (4)
• Continued fever or remittent fever (1)
f. Other underlying diseases (1)
2. Clinical symptoms
a. Acute renal failure
• Anuria ( ≤ 5 mL/hr) (4)
• Oliguria (5–20 mL/hr) (3)
b. Acute respiratory failure (amniotic fluid embolism excluded)
• Artificial ventilation or occasional assisted respiration (4)
• Oxygen flux alone (1)
c. Organ failure
• Heart (rales or foamy sputum, etc.) (4)
• Liver (visible jaundice, etc.) (4)
• Brain (clouding of consciousness, convulsion, etc.) (4)
• Digestive tract (necrotic enteritis, etc.) (4)
• Other severe organ failure (4)
d. Hemorrhage diathesis (4)
Macroscopic hematuria and melena, purpura, hemorrhage from the mucous membrane, gingival bleeding, 
bleeding at the site of injection, etc.
e. Shock symptoms
• Pulse rate ≥ 100/min (1)
• Blood pressure ≤ 90 mmHg (systolic) or blood pressure reduction of  ≥ 40% (1)
• Cold sweat (1)
• Pallor (1)
3. Laboratory findings
• Serum FDP ≥ 10 µg/mL (1)
• Platelet counts ≤ 10 × 104/µL (1)
• Fibrinogen ≤ 150 mg/dL (1)
• PT ≥ 15 (s) ( ≤ 50%) or hepaplastin test ≤ 50% (1)
• Erythrocyte sedimentation rate ≤ 4 mm/15 min or ≤ 15 mm/hr (1)
• Bleeding time ≥ 5 min (1)
• Other coagulation and fibrinolysis factors ; AT ≤ 18 mg/dL or ≤ 60%, prekallikrein, α2-PI, plasminogen, 
other coagulation factors ≤ 50%
(1)
α2-PI, α2-plasmin inhibitor ; AT, antithrombin ; CTG, cardiotocography ; DIC, disseminated intravascular coagulation ; FDP, 
fibrin degradation product ; PT, prothrombin time.
Obstetrical DIC could be diagnosed to initiate therapy for DIC when the obstetrical DIC score reaches 8 points or more without 
waiting for the results of coagulation tests.
An obstetrical DIC score ≥ 13 points, including at least two coagulation tests, however, is compatible to the diagnostic criteria for 
DIC.
This case met 1b (artificial ventilation), 2b (artificial ventilatoin), 2c (brain), 2d, 2e (pulse rate, blood pressure), 3 (FDP, platelet, 
fibrinogen, PT), and the total score was 21 points.
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obstetrical DIC (7). In the present case, it was diagnosed clinical-
ly as cardiopulmonary collapse type of AFE (2), because dyspnea 
and loss of consciousness were the first symptoms. As there was 
no pathological specimen, a definitive diagnosis could not be 
made in the present case. But the serum AFE diagnostic marker 
was positive for C1 inhibitor activity. Oda et al., suggested that 
C1 inhibitor activity is superior as a pathophysiologic indicator 
to markers that reflect amniotic fluid influx into the maternal 
circulation (11). Tamura et al., demonstrated that low C1 inhibi-
tor activity levels were closely associated with the pathogenesis 
of AFE suggesting that C1 inhibitor activity level have potential 
as a prognosis factor of AFE (12).
On the other hand, this case had two contradictory findings 
as cardiopulmonary collapse type. One was the findings of TEE. 
When entry of amniotic fluid into the maternal circulation re-
sulted in obstruction of pulmonary capillaries by amniotic fluid 
emboli, leading to cardiovascular collapse, the images of TEE 
may demonstrate severe pulmonary hypertension, acute right 
ventricular failure with a leftward deviation of the interatrial 
and interventricular septum, and a cavity-obliterated left ven-
tricle during the early phase of AFE (8). However, intraoperative 
TEE showed that her right ventricle collapse and hyperkinetic 
movement of left ventricle, but not acute right ventricular fail-
ure. These findings suggest that anaphylaxis-like vasodilation, 
but not pulmonary embolism, occurred in the present case.
The other one was serum test findings. Supplemental diagnos-
tic markers for AFE in maternal serum include Zn-CP1, STN, 
C3, C4, and IL-8. Zn-CP1 and STN tend to be high in patients 
with the cardiopulmonary collapse type of AFE. C3 and C4 are 
low in uterine type AFE (6). In the present case, C1 inhibitor 
activity was low and C4 was at the lower limit of normal, but 
Zn-CP 1 and STN did not meet the diagnostic criteria (Table 
1). These findings suggest that the anaphylactoid reaction was 
central to the condition, while the influx of fetal components was 
small. The reaction caused vasodilation and hypotension, and 
combined the blood loss due to hemorrhage may also result in 
the Bezold-Jarisch reflex. As the results, she had bradycardia, 
dyspnea, and loss of consciousness. Although no histopatholog-
ical diagnosis can be made due to the absence of tissue removal 
including the uterus, it may be possible as one of the hypotheses.
It is reported that the presence of fetal cells in the pulmonary 
vessels is not reliable for diagnostic criterion for AFE, as fetal 
components can be detected in 21% of pregnant women without 
AFE (1, 8). Recently, the onset of AFE is thought to require two 
conditions : (1) an influx of fetal components into the maternal 
circulation, and (2) a significant pulmonary embplus or mater-
nal immune/aphylactoid reaction against the amniotic fluid or 
fetal components (1). In the present case, immun reaction pre-
dominated, and anaphylactoid reaction and DIC were thought 
to be caused.
Few reports to date have described patients experiencing AFE 
during cesarean section. Initial symptoms of AFE include hypo-
tension, dyspnea, loss of consciousness, and seizure-like activity 
(3), with the sudden appearance of these symptoms during awake 
cesarean section indicating suspected AFE. Early diagnosis and 
treatment are important for patient survival (3). Depending on 
the symptoms, airway and/or vascular management may be re-
quired. DIC indicates the need for blood transfusion, especially 
of FFP (fibrinogen). Some patients may also require extracorpo-
real membrane oxygenation or intra-aortic balloon pumping (9). 
Because a patient with AFE developed acute respiratory distress 
syndrome 24 hours after cesarean section, patients should be 
carefully monitored for several days after AFE (10).
Reported risk factors for AFE include maternal age ≥ 35 years, 
cesarean delivery, forceps-assisted and vacuum-assisted vaginal 
deliveries, placenta previa, abruption placenta, eclampsia, and 
fetal distress (8). The patient described in this report had un-
dergone a cesarean delivery. Although she also underwent fetal 
thoracoamniotic shunting surgery at 22 weeks of pregnancy, we 
found no evidence indicating that fetal surgery was a risk factor 
for AFE. However, fetal surgery may sensitize the mother to 
immunologic reaction to amniotic fluid.
In the present case, the uterus was preserved and the patient 
survived without any sequelae because of early treatment and 
proper blood transfusion and whole body management. AFE 
should be considered if the condition of the patient changes sud-
denly during cesarean section.
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